I

International Clinical Research | Murfreesboro, TN

Research site

(Unclaimed)

Location

1035 N Highland Avenue, Murfreesboro, Tennessee, United States of America

Site insights

Top conditions

Top treatments

fezolinetant

Lebrikizumab

Baricitinib

Dupilumab

LY3009104

Ixekizumab

CC-93538

Guselkumab

Cendakimab

Parent organization

This site is a part of International Clinical Research

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hai...

Enrolling

Hair Diseases

Alopecia

Drug: Placebo

Drug: Baricitinib

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab (ADapt)

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting

Atopic Dermatitis

Drug: Lebrikizumab

Trial sponsors

S

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms